Financials

  • Market Capitalization 270.1473 M
  • Employee 213
  • Founded 1996
  • CEO N/A
  • Website www.simulations-plus.com
  • Headquarter North Carolina, United States
  • FIGI BBG000BS2ZD1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.47
Rapporto prezzo/fatturato
3.65
Dividendi per azione
Rendimento da dividendi %

Simulations Plus Inc

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

Notizie